GUSTAVO RAMIREZ GUILLEN: Open Payments
NPI 1164189692 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$797 in 37 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $100 · 2025 $797
Food & beverage: $797
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $334 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $105 |
| Lilly USA, LLC | 4 | $77 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Mallinckrodt Hospital Products Inc. | 2 | $45 |
| Phathom Pharmaceuticals, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| GENZYME CORPORATION | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: SKYRIZI, RINVOQ, LINZESS, ENTYVIO, OMVOH, DUPIXENT, REZDIFFRA, TERLIVAZ.
Industry payments across FL — which companies pay providers there.
